Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRC2.L Regulatory News (RC2)

  • There is currently no data for RC2

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of the Company's shareholding in Albalact SA

20 Sep 2016 13:28

RNS Number : 3469K
Reconstruction Capital II Ltd
20 September 2016
 

20 September 2016

 

Reconstruction Capital II Limited (the "Company")

Sale of the Company's shareholding in Albalact SA

Reconstruction Capital II Ltd ("RC2" or the "Company"), a closed-end investment company incorporated in the Cayman Islands admitted to trading on the AIM market of the London Stock Exchange, today announces that further to the announcement made on 5 August 2016 relating to the Public Offer for a voluntary takeover bid by Lactalis of Albalact SA, ("Albalact") a publicly quoted Romanian dairy company, and following the closing of the Public Offer on 14 September 2016, the Company's 166,100,478 shares, representing a 25.4% stake in Albalact, have been acquired by Lactalis at RON 0.5252 per share.

Accordingly, RC2 has received today a total of RON 87.027 million (net of brokerage fees), or EUR 19.572 million based on the exchange rate of 4.4464 RON to 1 EUR prevailing as at 20 September 2016. At this exchange rate, the Company has realised a gain of EUR 3.15 million on the book value of its holding in Albalact as at 30 June 2016, and a profit of EUR 14.9 million on the total cost of its investment.

In the first instance, the Directors intend to use the proceeds of the sale to repay the residual balance of the loan notes that have not already been converted, which was EUR 5.8 million as at 19 September 2016, to the extent that such loan notes are not subsequently converted into equity by their holders. Furthermore, the Directors intend to propose to the shareholders that the bulk of the balance be returned to them, having set aside an adequate amount for working capital purposes. An announcement with further details will be made in due course.

The information contained within this announcement is considered to be inside information prior to its release, as defined in Article 7 of the Market Abuse Regulation No. 596/2014, and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

For further information, please contact:

Reconstruction Capital II Limited

Ion Florescu/Anca Moraru

Tel: +40 21 3167680

Grant Thornton UK LLP (Nominated Adviser)

Philip Secrett/Carolyn Sansom

Tel:+ 44 (0) 20 7383 5100

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAANEAASKEFF
Date   Source Headline
13th Apr 20217:00 amRNSQuarterly report to 31 December 2020
26th Mar 202110:56 amRNSNew Valuations of Private Equity Positions
2nd Feb 20212:00 pmRNSLoan Arrangement
11th Nov 202010:54 amRNSQuarterly report
16th Oct 20203:17 pmRNSNet Asset Value(s)
21st Aug 20202:00 pmRNSInterim Unaudited Financial Statements
11th Aug 202012:00 pmRNSQuarterly Report
6th Aug 202011:00 amRNSLoan Facility
16th Jul 202012:36 pmRNSNet Asset Value and Quarterly Report
12th Jun 202010:51 amRNSAnnual Report and Audited Financial Statements
19th May 20209:30 amRNSQuarterly Report
27th Apr 20203:45 pmRNSNet Asset Value and Quarterly Report
9th Apr 202010:41 amRNSNAV, Quarterly Report
30th Mar 20202:30 pmRNSNew Valuations of Private Equity Positions
16th Dec 201910:40 amRNSTransaction in Own Shares
12th Dec 20191:52 pmRNSTransaction in Own Shares
15th Nov 201910:33 amRNSQuarterly Report
18th Oct 20191:09 pmRNSNet Asset Value and Quarterly Report
25th Sep 201911:44 amRNSDisposal of last plot of Policolor S.A. site
2nd Sep 201911:01 amRNSDirector Appointment
12th Aug 201911:12 amRNSInterim Unaudited Financial Statements
7th Aug 20192:49 pmRNSQuarterly report
22nd Jul 20199:33 amRNSNet Asset Value and Quarterly Report
14th Jun 20191:20 pmRNSAnnual Report and Audited Financial Statements
28th May 20195:58 pmRNSQuarterly report
3rd Apr 20193:19 pmRNSNew Valuations of Private Equity Positions
23rd Jan 20195:23 pmRNSTransaction in Own Shares
23rd Jan 201912:31 pmRNSTransaction in Own Shares
21st Dec 20185:27 pmRNSTransaction in Own Shares, Purchase of RIF Shares
18th Dec 20185:08 pmRNSDirector Resignation
16th Nov 20184:27 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Nov 201811:34 amRNSQuarterly Report
22nd Oct 20189:05 amRNSNet Asset Value and Quarterly Report
20th Aug 20189:16 amRNSInterim Unaudited Financial Statements
14th Aug 20183:41 pmRNSQuarterly Report
3rd Aug 20181:24 pmRNSNet Asset Value and Quarterly Report
19th Jul 20183:03 pmRNSTransaction in Own Shares and Total Voting Rights
13th Jul 201812:25 pmRNSTransaction in Own Shares and Total Voting Rights
9th Jul 201810:37 amRNSHolding(s) in Company
20th Jun 20185:32 pmRNSAnnual Report and Audited Financial Statements
10th May 20183:11 pmRNSNet Asset Value and Quarterly Report
14th Mar 20187:00 amRNSNAV, Quarterly Report and New PE Valuations
21st Feb 20182:51 pmRNSResult of AGM
26th Jan 201812:00 pmRNSPublication of Circular
12th Jan 20181:33 pmRNSProposed acquisition & change of investing policy
19th Dec 20174:37 pmRNSNet Asset Value and Monthly Report
29th Nov 20174:38 pmRNSNet Asset Value and Monthly Report
20th Nov 20177:00 amRNSChange of Adviser
13th Nov 201711:02 amRNSQuarterly Report
31st Oct 20174:33 pmRNSNet Asset Value and Quarterly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.